Open AccessCapecitabine with radiation is an effective adjuvant therapy in gastric cancers
Author(s) -
Chee Kian Tham
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i29.3709
Subject(s) - medicine , capecitabine , epirubicin , chemotherapy , radiation therapy , gastroenterology , fluorouracil , oncology , cancer , mucositis , stage (stratigraphy) , surgery , cyclophosphamide , colorectal cancer , biology , paleontology
To analyze the outcome of patients who received concurrent capecitabine (Xeloda) and radiation (XRT) compared to the established concurrent 5-fluorouracil (5-FU) with radiation (5FU-RT) and fluoropyrimidine-based chemotherapy alone as adjuvant treatment in gastric cancers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom